Mount Yale Investment Advisors LLC Raises Position in Zoetis Inc. (NYSE:ZTS)

Mount Yale Investment Advisors LLC increased its holdings in Zoetis Inc. (NYSE:ZTS) by 12.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,366 shares of the company’s stock after purchasing an additional 493 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Zoetis were worth $757,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in ZTS. Focus Financial Network Inc. ADV acquired a new position in shares of Zoetis during the 4th quarter valued at about $2,159,000. Price T Rowe Associates Inc. MD grew its holdings in Zoetis by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after purchasing an additional 3,244,074 shares during the period. Axiom Investors LLC DE increased its position in Zoetis by 36.3% during the fourth quarter. Axiom Investors LLC DE now owns 594,474 shares of the company’s stock worth $117,331,000 after purchasing an additional 158,459 shares during the last quarter. Global Assets Advisory LLC purchased a new position in Zoetis during the first quarter worth approximately $8,831,000. Finally, Franklin Street Advisors Inc. NC boosted its holdings in shares of Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock valued at $20,478,000 after purchasing an additional 5,035 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Zoetis Trading Up 0.5 %

ZTS opened at $193.59 on Tuesday. The firm’s 50 day moving average is $185.01 and its 200-day moving average is $174.42. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The firm has a market capitalization of $88.33 billion, a P/E ratio of 37.30, a P/E/G ratio of 2.98 and a beta of 0.88.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.41 EPS. Analysts expect that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on ZTS shares. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. BTIG Research lifted their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus raised their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Finally, Piper Sandler boosted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $220.38.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.